SCHEMBL7410232

SCHEMBL7410232

Cc1ccn2c(Cc3ncc[nH]3)c(-c3ccc(Cl)cn3)nc2c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1H4 Q96RI1 1/20 0.39
SMN1; SMN2 Q16637 7/20 0.36
GAA P10253 5/20 0.36
HTT P42858 4/20 0.36
KMT2A Q03164 3/20 0.36
NPSR1 Q6W5P4 3/20 0.36
TDP1 Q9NUW8 3/20 0.36
MITF O75030 1/20 0.36
ALDH1A1 P00352 4/20 0.36
MAPT P10636 3/20 0.36
POLB P06746 3/20 0.36
KDM4E B2RXH2 2/20 0.36
CYP11B1 P15538 1/20 0.35
CYP11B2 P19099 1/20 0.35
TP53 P04637 2/20 0.35
RAB9A P51151 2/20 0.34
NPC1 O15118 1/20 0.34
LMNA P02545 2/20 0.34
GFER P55789 1/20 0.34
TAAR1 Q96RJ0 3/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7374857 0.91 GAA (0.40) SMN1; SMN2GAAHTTKMT2ANPSR1
SCHEMBL7379148 0.78 PSMD14 (0.40) SMN1; SMN2HTTALDH1A1POLBKDM4E
SCHEMBL7559581 0.78 NPC1 (0.45) NR1H4SMN1; SMN2GAAHTTKMT2A
SCHEMBL7407222 0.76 KDM4E (0.40) SMN1; SMN2GAAHTTKMT2AALDH1A1
SCHEMBL7378397 0.74 SIRT5 (0.39) SMN1; SMN2GAAHTTALDH1A1POLB
SCHEMBL7372340 0.72 SIRT5 (0.41) ALDH1A1POLB
SCHEMBL7377978 0.71 KCNK3 (0.40) SMN1; SMN2GAAHTTPOLBKDM4E
SCHEMBL7243478 0.71 CYP11B1 (0.40) SMN1; SMN2GAAHTTKMT2ANPSR1
SCHEMBL7412126 0.70 DPP4 (0.39) GAAMAPTPOLBTP53TAAR1
SCHEMBL7238599 0.69 ALDH1A1 (0.44) SMN1; SMN2HTTALDH1A1MAPTPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2002002557-A2 2-PHENYLIMIDAZO[1,2-A]PYRIDINE DERIVATIVES: A NEW CLASS OF GABA BRAIN RECEPTOR LIGANDS NEUROGEN CORPORATION (US) 2002-01-10 WO claimed